Immunostimulatory and immunomodulatory peptides derived from the α1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats

Immunobiology

Volumn 209, Issue 10, 2005, Pages 711-717

  Diedrichs Möhring, Maria ^a   Wildner, Gerhild ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arthritis; Autoimmune disease; HLA B27 peptide; Oral tolerance; T lymphocytes; Uveitis

Indexed keywords

EPITOPE; HLA B27 ANTIGEN; HLA B27 ANTIGEN DERIVATIVE; PROTEIN DERIVATIVE; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MALE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR DOWN REGULATION; SCORING SYSTEM; UVEITIS;

EID: 18244370759     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2004.12.004     Document Type: Article

References (32)

1. D.A. Brewerton F.D. Hart A. Nicholls M. Caffrey D.C. James R.D. Sturrock Ankylosing spondylitis and HL-A 27 Lancet 1 1973 904-907
2. D.A. Brewerton M. Caffrey A. Nicholls D. Walters D.C. James Letter: acute anterior uveitis and HL-A 27 Lancet 1 1974 464
3. R. Buelow P. Veyron C. Clayberger P. Pouletty J.L. Touraine Prolongation of skin allograft survival in mice following administration of ALLOTRAP Transplantation 59 1995 455-460
4. A. Cauli G. Dessole M.T. Fiorillo A. Vacca A. Mameli P. Bitti G. Passiu R. Sorrentino A. Mathieu Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: A possible further susceptibility factor for the development of disease Rheumatology (Oxford) 41 2002 1375-1379
5. J.H. Chen D.H. Kono Z. Yong M.S. Park M.M. Oldstone D.T. Yu A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27 J. Immunol. 139 1987 3003-3011
6. C. Clayberger S.C. Lyu P. Pouletty A.M. Krensky Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses Transplant. Proc. 25 1993 477-478
7. M.D. de Smet G. Bitar F.G. Roberge I. Gery R.B. Nussenblatt Human S-antigen: Presence of multiple immunogenic and immunopathogenic sites in the Lewis rat J. Autoimmun. 6 1993 587-599
8. J. Friedman I. Weissman Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA Cell 66 1991 799-806
9. S. Guha T.K. Manna K.P. Das B. Bhattacharyya Chaperone-like activity of tubulin J. Biol. Chem. 273 1998 30077-30080
10. E. Hermann D.T. Yu K.H. Meyer zum Buschenfelde B. Fleischer HLA-B27-restricted CD8T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis Lancet 342 1993 646-650
11. S. Iyer J. Woo M.C. Cornejo L. Gao W. McCoubrey M. Maines R. Buelow Characterization and biological significance of immunosuppressive peptide D2702.75-84(E→V) binding protein. Isolation of heme oxygenase-1 J. Biol. Chem. 273 1998 2692-2697
12. K. Kapasi R.D. Inman HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells J. Immunol. 148 1992 3554-3559
13. A.M. Krensky C. Clayberger The induction of tolerance to alloantigens using HLA-based synthetic peptides Curr. Opin. Immunol. 6 1994 791-796
14. O. Lider L.M. Santos C.S. Lee P.J. Higgins H.L. Weiner Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+T lymphocytes J. Immunol. 142 1989 748-752
15. W.P. Maksymowych T. Ikawa A. Yamaguchi M. Ikeda D. McDonald L. Laouar R. Lahesmaa N. Tamura A. Khuong D.T. Yu K.P. Kane Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27 Infect. Immun. 66 1998 4624-4632
16. E. Marker Hermann K.H. Meyer zum Buschenfelde G. Wildner HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis Arthritis Rheum. 40 1997 2047-2054
17. P. Moseley Stress proteins and the immune response Immunopharmacology 48 2000 299-302
18. E. Nossner J.E. Goldberg C. Naftzger S.C. Lyu C. Clayberger A.M. Krensky HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family J. Exp. Med. 183 1996 339-348
19. R.B. Nussenblatt R.R. Caspi R. Mahdi C.C. Chan F. Roberge O. Lider H.L. Weiner Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen J. Immunol. 144 1990 1689-1695
20. P.L. Schwimmbeck D.T. Yu M.B. Oldstone Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease J. Exp. Med. 166 1987 173-181
21. R.H. Scofield B. Kurien T. Gross W.L. Warren J.B. Harley HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies Lancet 345 1995 1542-1544
22. N.H. Sigal F.J. Dumont Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction Annu. Rev. Immunol. 10 1992 519-560
23. D. Sun J.N. Whitaker D.B. Wilson Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease Int. Immunol. 11 1999 307-315
24. R. Tarazona G. Lopez Lluch M.D. Galiani E. Aguado F. Barahona R. Solana J. Pena HLA-B2702 (77-83/83-77) peptide binds to beta-tubulin on human NK cells and blocks their cytotoxic capacity J. Immunol. 165 2000 6776-6782
25. S.R. Thurau C.C. Chan E. Suh R.B. Nussenblatt Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide J. Autoimmun. 4 1991 507-516
26. G. Wildner S.R. Thurau Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: A clue to major histocompatibility complex association with autoimmune disease Eur. J. Immunol. 24 1994 2579-2585
27. G. Wildner T. Hunig S.R. Thurau Orally induced, peptide-specific gamma/ delta TCR+ cells suppress experimental autoimmune uveitis Eur. J. Immunol. 26 1996 2140-2148
28. G. Wildner M. Diedrichs Mohring S.R. Thurau Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin Eur. J. Immunol. 32 2002 299-306
29. G. Wildner M. Diedrichs Mohring Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo Int. Immunol. 15 2003 927-935
30. J. Woo L. Gao M.C. Cornejo R. Buelow A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model Transplantation 60 1995 1156-1163
31. J. Woo S. Iyer M.C. Cornejo L. Gao C. Cuturi J.P. Soulillou R. Buelow Immunosuppression by D-isomers of HLA class I heavy chain (amino acid 75 to 84)-derived peptides is independent of binding to HSC70 Transplantation 64 1997 1460-1467
32. J. Woo S. Iyer M.C. Cornejo N. Mori L. Gao I. Sipos M. Maines R. Buelow Stress protein-induced immunosuppression: Inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32) Transplant. Immunol. 6 1998 84-93